Further evidence of a dose-response threshold for haloperidol in psychosis
Abstract
OBJECTIVE: The authors' goal was to determine whether higher doses of haloperidol improve antipsychotic response. METHOD: During a 2-week, double-blind, randomized fixed-dose study, 24 psychotic patients were given 4, 10, or 40 mg/day of haloperidol. RESULTS: No clinically relevant difference between groups in favor of the higher antipsychotic doses could be detected. CONCLUSIONS: Doses of 4 mg/day of haloperidol appear to be as effective as higher doses in the treatment of psychosis.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
